Schedule of basic and diluted net loss per share |
|
|
For the Year Ended December 31, 2020
|
|
|
|
Loss
(Numerator)
|
|
|
Shares
(Denominator)
|
|
|
Per-Share
Amount
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$ |
(6,560,699 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
|
|
|
|
|
|
|
|
|
Loss available to common stockholders
|
|
|
(6,560,699 |
) |
|
|
230,746,878 |
|
|
$ |
(0.03 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of Dilutive Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants – liability classified
|
|
|
(345,473
|
) |
|
|
674,095 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss available to common stockholders + assumed conversions
|
|
$ |
(6,906,172 |
) |
|
|
231,420,973 |
|
|
$ |
(0.03
|
) |
|
|
For the Year Ended December 31, 2019
|
|
|
|
Income
(Numerator)
|
|
|
Shares
(Denominator)
|
|
|
Per-Share
Amount
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
1,051,825 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
|
|
|
|
|
|
|
|
|
Income available to common stockholders
|
|
|
1,051,825 |
|
|
|
135,154,931 |
|
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of Dilutive Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested restricted stock
|
|
|
|
|
|
|
858,856 |
|
|
|
|
|
Options
|
|
|
|
|
|
|
392,784 |
|
|
|
|
|
Warrants
|
|
|
|
|
|
|
447,431 |
|
|
|
|
|
Warrants – liability classified
|
|
|
(9,250,612
|
) |
|
|
32,706,263
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss available to common stockholders + assumed conversions
|
|
$ |
(8,198,787 |
) |
|
|
169,560,265 |
|
|
$ |
(0.05 |
) |
|
Schedule of anti-dilutive securities |
|
|
Year Ended
December 31,
|
|
|
|
2020
|
|
|
2019
|
|
Stock options
|
|
|
22,050,000 |
|
|
|
4,119,931 |
|
Unvested restricted stock
|
|
|
— |
|
|
|
234,645 |
|
Common shares underlying convertible debt
|
|
|
5,126,343 |
|
|
|
5,036,250 |
|
Warrants
|
|
|
145,039,240 |
|
|
|
20,712,000 |
|
|